Valley Brook Capital Group Inc. Has $377,000 Stock Position in CVS Health Co. (NYSE:CVS)

Valley Brook Capital Group Inc. trimmed its stake in shares of CVS Health Co. (NYSE:CVS) by 6.8% during the fourth quarter, Holdings Channel reports. The firm owned 4,771 shares of the pharmacy operator’s stock after selling 350 shares during the period. Valley Brook Capital Group Inc.’s holdings in CVS Health were worth $377,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the stock. TCI Wealth Advisors Inc. boosted its holdings in CVS Health by 2.5% during the fourth quarter. TCI Wealth Advisors Inc. now owns 16,880 shares of the pharmacy operator’s stock valued at $1,333,000 after purchasing an additional 411 shares in the last quarter. Sheets Smith Wealth Management raised its stake in shares of CVS Health by 68.0% in the fourth quarter. Sheets Smith Wealth Management now owns 107,301 shares of the pharmacy operator’s stock valued at $8,472,000 after acquiring an additional 43,426 shares during the last quarter. River Global Investors LLP bought a new position in shares of CVS Health in the fourth quarter valued at approximately $261,000. FourThought Financial Partners LLC raised its stake in shares of CVS Health by 10.1% in the fourth quarter. FourThought Financial Partners LLC now owns 6,546 shares of the pharmacy operator’s stock valued at $517,000 after acquiring an additional 599 shares during the last quarter. Finally, TCG Advisory Services LLC raised its stake in shares of CVS Health by 730.0% in the fourth quarter. TCG Advisory Services LLC now owns 80,208 shares of the pharmacy operator’s stock valued at $6,333,000 after acquiring an additional 70,544 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Up 1.4 %

Shares of CVS stock traded up $0.75 on Friday, hitting $55.90. The stock had a trading volume of 23,946,075 shares, compared to its average volume of 12,498,538. CVS Health Co. has a twelve month low of $53.70 and a twelve month high of $83.25. The firm has a market cap of $70.18 billion, a P/E ratio of 9.82, a PEG ratio of 0.88 and a beta of 0.56. The company has a current ratio of 0.81, a quick ratio of 0.63 and a debt-to-equity ratio of 0.78. The company has a fifty day moving average price of $72.77 and a two-hundred day moving average price of $73.29.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. During the same period last year, the firm earned $2.20 EPS. CVS Health’s quarterly revenue was up 3.7% on a year-over-year basis. As a group, analysts forecast that CVS Health Co. will post 7.03 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.76%. The ex-dividend date was Friday, April 19th. CVS Health’s payout ratio is presently 46.75%.

Analyst Ratings Changes

A number of research firms have recently issued reports on CVS. Royal Bank of Canada cut their target price on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Barclays cut their target price on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday. Cantor Fitzgerald cut shares of CVS Health from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $87.00 to $58.00 in a research report on Wednesday. SVB Leerink restated a “market perform” rating and issued a $60.00 price objective (down previously from $87.00) on shares of CVS Health in a research report on Wednesday. Finally, Piper Sandler boosted their price objective on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Eight research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $80.35.

Insider Buying and Selling

In related news, Director Edward J. Ludwig bought 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average cost of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other CVS Health news, Director Edward J. Ludwig acquired 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The stock was bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The disclosure for this sale can be found here. Company insiders own 0.24% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.